On 4 June 2016, new criminal provisions to contain corruption in the health sector have been entered in force. It is recommendable to review forms of cooperation between pharmaceutical companies and medical device manufactures or hospitals with members of the healthcare professions, especially with physicians in private practice. In this context, it is possible to build up risk management strategies based on already existing high standards concerning the cooperation with public hospitals.
We have composed the attached newsletter that provides an overview about the new regime.
If you have any questions please do not hesitate to contact us.